STOCK TITAN

Morgan Stanley Smith Barney reports sale of 2,500 VERA shares (VERA)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC reported the sale of 2,500 restricted common shares under a registered plan, with the transaction dated 02/20/2026 and the Form 144 filed on 02/23/2026. The filing lists an aggregate amount of $105,087.50 and identifies the exchange as NASDAQ.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 sale notice for vested restricted shares, routine compliance disclosure.

The excerpt shows a sale of 2,500 common shares described as "restricted stock vesting under a registered plan" with a transaction date of 02/20/2026 and an aggregate figure of $105,087.50.

Such filings are administrative notifications that permit resale under Rule 144 conditions; cash‑flow treatment and buyer identity are not provided in the excerpt. Subsequent filings may disclose settlement details.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for VERA show?

The Form 144 reports the sale of 2,500 restricted common shares dated 02/20/2026. The filing lists an aggregate amount of $105,087.50 and was filed on 02/23/2026.

Who is the selling party on the Form 144 for VERA?

The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the reporting broker/agent for the transaction. The excerpt labels the transaction as related to the issuer under a registered plan.

What kind of shares were sold according to the VERA filing?

The shares are described as restricted stock vesting under a registered plan. The transaction date is 02/20/2026 and the sale quantity is 2,500 common shares.

Does the Form 144 state which exchange VERA trades on?

Yes. The excerpt lists the exchange as NASDAQ. The filing also contains the transaction and filing dates of 02/20/2026 and 02/23/2026, respectively.

Is the cash‑flow recipient specified in the VERA Form 144?

The excerpt does not specify who receives the sale proceeds. The Form 144 shows an aggregate figure of $105,087.50, but it does not state the recipient or use of proceeds.
Vera Therapeutics, Inc.

NASDAQ:VERA

VERA Rankings

VERA Latest News

VERA Latest SEC Filings

VERA Stock Data

2.99B
69.16M
Biotechnology
Pharmaceutical Preparations
Link
United States
BRISBANE